<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR123">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Schwab</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Schneider-Hohendorf</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Melzer</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Cutter</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Wiendl</surname>
    <given-names>H</given-names>
   </name>
  </person-group>
  <article-title>Natalizumab-associated PML: challenges with incidence, resulting risk, and risk stratification</article-title>
  <source>Neurology</source>
  <year>2017</year>
  <volume>88</volume>
  <issue>12</issue>
  <fpage>1197</fpage>
  <lpage>1205</lpage>
  <pub-id pub-id-type="pmid">28228564</pub-id>
 </element-citation>
</ref>
